Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Voxzogo
Pharma
BioMarin touts pipeline asset as potential Voxzogo replacement
Competition is coming for BioMarin’s Voxzogo, but it may be able to answer with a longer-acting version of the drug, which treats a form of dwarfism.
Kevin Dunleavy
Aug 5, 2025 11:30am
BioMarin unveils strategic redesign under CEO Alexander Hardy
Sep 4, 2024 5:32pm
With slow sales, BioMarin weighs Roctavian divestiture
Apr 29, 2024 11:51am
BioMarin's hemophilia gene therapy needs 3 stars to align: CEO
Feb 23, 2024 10:15am
BioMarin’s commercial chief Jeffrey Ajer hits the exit
Jan 12, 2024 10:28am
JPM24: New BioMarin CEO Hardy makes his priorities clear
Jan 10, 2024 11:29am
